DOCSLIB.ORG

Federal Register / Vol. 62, No. 158 / Friday, August 15, 1997 / Rules and Regulations

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Federal Register / Vol. 62, No. 158 / Friday, August 15, 1997 / Rules and Regulations 43820 Federal Register / Vol. 62, No. 158 / Friday, August 15, 1997 / Rules and Regulations ENVIRONMENTAL PROTECTION standard can modify these guidelines as Agency experts and, in some instances, AGENCY needed for an individual test substance. presented at domestic and international The Agency uses a system where colloquia to solicit the views of 40 CFR Part 799 standardized guidelines are organized recognized experts and the regulated by testing endpoint and codified in a community. The draft harmonized [OPPTS±42193; FRL±5719±5] subpart of this part. When a test rule is guidelines are made available as public RIN 2070±AB76 promulgated, the test standard specified drafts. A notice is published in the in the test rule cross-references the Federal Register announcing their Toxic Substances Control Act Test guideline for the bulk of the testing availability and soliciting public Guidelines requirements. In this context, the public comment. is given notice of, and an opportunity to Seven of the 11 health effects test AGENCY: Environmental Protection comment on, the guidelines as they are guidelines that are being codified in Agency (EPA). applied in chemical-specific test rules. subpart H of 40 CFR part 799 have their ACTION: Final rule. This approach eliminates the need to origin in this harmonization process. A repeat the same test specifications for notice was published in the Federal SUMMARY: This rule establishes 11 Toxic each substance-specific test rule since Register of June 20, 1996, (61 FR 31522 Substances Control Act (TSCA) health most of the specifications for testing do (FRL±5367±7)) announcing the effects test guidelines in the Code of not change across substances. The test availability of the proposed test Federal Regulations (CFR). specifications in a guideline can be guidelines for Series 870ÐHealth Establishment of these guidelines is varied, when necessary, to the specific Effects Test Guidelines and soliciting necessary to ensure enforceable test requirements of a test rule by language public comment. Comments were standards in test rules promulgated in the test rule itself. received, and a meeting of the Agency's under section 4 of TSCA. Codification of In 1985, the Agency established a set Federal Insecticide, Fungicide, and this series of TSCA test guidelines does of TSCA test guidelines in 40 CFR parts Rodenticide Act (FIFRA) Scientific not by itself impose obligations upon 795 through 798 (50 FR 39252, Advisory Panel (SAP) was held on any person. Obligations are only September 27, 1985). These guidelines October 29 and 30, 1996. The SAP, an imposed when these guidelines are were established as standardized advisory committee consisting of cross-referenced in a test rule protocols for laboratory testing of an scientific experts both inside and promulgated under section 4 of TSCA. effect or characteristic deemed outside the U.S. Government, reviewed DATES: This rule is effective on August important for the evaluation of health or the guidelines and made comments. The 15, 1997. environmental hazards of a chemical. Agency reviewed these comments in developing the harmonized health FOR FURTHER INFORMATION CONTACT: Standardized guidelines are necessary effects guidelines. Susan Hazen, Director, Environmental for the establishment of enforceable test Four of the 11 guidelines Assistance Division (7408), Office of standards in test rules promulgated (§ § 799.9510, 799.9530, 799.9538, and Pollution Prevention and Toxics, under section 4 of TSCA. 799.9539) were initially developed by Environmental Protection Agency, Rm. The Agency has over time amended the OECD. E-543B, 401 M St., SW., Washington, DC and improved these guidelines (52 FR 20460; telephone: (202) 554±1404; TDD: 19072, May 20, 1987). In order to reduce III. TSCA Test Guidelines (202) 554±0551; e-mail: TSCA- the text of the CFR, the Agency deleted those guidelines which had not been Harmonization has resulted in [email protected]. For specific significantly improved guidelines. information regarding this action or cited in any test rules (60 FR 31917, June 19, 1995 (FRL±4955±2)). However, creating a single set of related activities, please contact Roger guidelines which can be used by both Nelson, Chemical Control Division, II. OPPTS Harmonized Test Guidelines OPP, in its administration of the FIFRA OPPT; telephone: (202) 260±8163; e- EPA is undertaking a comprehensive and the Federal Food, Drug and mail: [email protected]. modification, or harmonization, of its Cosmetic Act (FFDCA), and the Office of SUPPLEMENTARY INFORMATION: This final pesticides and toxics guidelines for Pollution Prevention and Toxics rule establishes a new series of TSCA testing of health effects, environmental (OPPT), which administers TSCA test guidelines in the CFR. effects, and chemical fate. The rationale presented certain challenges. Under FIFRA, test guidelines are used I. Introduction for this harmonization is to incorporate state of the art science, and to minimize in an interactive process between the Section 4(b)(1)(B) of TSCA requires variations among the protocols Agency and registrants seeking that test rules promulgated under the contained in: registration of pesticides or food residue authority of TSCA section 4 include 1. Test guidelines developed by the tolerances. Flexibility to tailor required ``standards for the development of test EPA Office of Pesticide Programs (OPP), testing to individual circumstances is data for such substance or mixture * * which appeared in publications of the critical, and the Agency has *.'' Test rules promulgated under TSCA National Technical Information Service. considerable discretion to determine section 4 must specify the standards for 2. The series of TSCA test guidelines whether submitted test results are the development of data. Standards established in 1985, which are adequate to support the requested established in test rules for the contained in 40 CFR parts 795, 796, 797, action. Under this scheme, registrants development of data must specify how and 798. have an intrinsic motivation to conduct the study is to be conducted, what data 3. Guidelines published by the well-grounded testing. Thus, pesticide will be collected, and how the data will Organization for Economic Cooperation testing protocols tend to have few be analyzed. The Agency has found that and Development (OECD). absolute requirements specifying the these specifications to a large degree can Harmonization operates as follows: details of the conduct of the testing. be standardized into a common set of EPA scientists develop guidelines (or By contrast the Agency is required protocols, or, as the Agency terms them, modify existing guidelines) for specific under section 4 of TSCA to impose ``guidelines.'' These guidelines are endpoints. The new or rewritten prescriptive test requirements by notice organized by testing endpoint. Each test guidelines are reviewed by other and comment rulemaking. Rules Federal Register / Vol. 62, No. 158 / Friday, August 15, 1997 / Rules and Regulations 43821 promulgated under section 4 of TSCA older, 1985 non-harmonized guidelines essentially those resulting from the specify classes of affected parties, in 40 CFR parts 795 through 798. The harmonization process with minor usually manufacturers and processors of only significant difference between the changes to promote enforceability. EPA the chemical being specified for testing, TSCA test guidelines and the OPPTS has elected to codify these new rather than interacting with companies harmonized test guidelines is that guidelines in part 799 so as to on an individual basis. These certain recommended procedures in the distinguish them from the pre- rulemakings typically take years to OPPTS harmonized test guidelines are harmonization guidelines in 40 CFR complete. Without initiating another made mandatory (i.e., the guideline parts 795 through 798. rulemaking process, the Agency has the states that they ``shall'' be carried out). These guidelines will be placed in a ability to require further testing only if IV. Codification in 40 CFR Part 799 new subpart H of part 799. In addition, the tests were not conducted in EPA plans to reserve additional subparts The Agency had originally planned accordance with the procedures of part 799 for test guidelines, so that not to publish the guidelines in the CFR, specified in the test rule. In addition, the structure of part 799 would be as but to instead make the guidelines the Agency has an alternative process of follows: negotiating TSCA testing requirements available via other means (such as the via enforceable consent agreements Internet) and reference the guidelines in Subpart AÐGeneral Provisions (ECAs), but these agreements require the specific test rules using the Subpart BÐSpecific Chemical Test consent of all the parties involved. incorporation by reference procedures Rules provided by 5 U.S.C. 552(a)(1)(E) and 1 Under TSCA section 4 enforceable Subpart CÐTesting Consent Orders test standards, much in the conduct of CFR part 51. In the Federal Register these test protocols is left to the document proposing the TSCA section 4 Subpart DÐMultichemical Test Rules judgment of those professionals test rule for 21 hazardous air pollutant Subpart EÐG [Reserved] conducting the testing. EPA believes substances (HAPs) (61 FR 33178, 33187, Subpart HÐHealth Effects Test that certain provisions must be June 26, 1996 (FRL±4869±1)), the Guidelines mandatory whenever the guidelines are Agency stated that it was considering cross-referenced
Load more

Recommended publications
  • Use of Polyphenolic Compounds in Dermatologic Oncology Adilson Costa, Emory University Michael Yi Bonner, Emory University Jack Arbiser, Emory University
    Use of Polyphenolic Compounds in Dermatologic Oncology Adilson Costa, Emory University Michael Yi Bonner, Emory University Jack Arbiser, Emory University Journal Title: American Journal of Clinical Dermatology Volume: Volume 17, Number 4 Publisher: Adis | 2016-08-01, Pages 369-385 Type of Work: Article | Post-print: After Peer Review Publisher DOI: 10.1007/s40257-016-0193-5 Permanent URL: https://pid.emory.edu/ark:/25593/s99z6 Final published version: http://dx.doi.org/10.1007/s40257-016-0193-5 Copyright information: © 2016, Springer International Publishing Switzerland (outside the USA). Accessed September 26, 2021 2:39 AM EDT HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Am J Clin Manuscript Author Dermatol. Author Manuscript Author manuscript; available in PMC 2018 April 16. Published in final edited form as: Am J Clin Dermatol. 2016 August ; 17(4): 369–385. doi:10.1007/s40257-016-0193-5. Use of Polyphenolic Compounds in Dermatologic Oncology Adilson Costa1, Michael Yi Bonner1, and Jack L. Arbiser1 1Department of Dermatology, Emory University School of Medicine, Atlanta Veterans Administration Medical Center, Winship Cancer Institute, 101 Woodruff Circle, Atlanta, GA 30322, USA Abstract Polyphenols are a widely used class of compounds in dermatology. While phenol itself, the most basic member of the phenol family, is chemically synthesized, most polyphenolic compounds are found in plants and form part of their defense mechanism against decomposition. Polyphenolic compounds, which include phenolic acids, flavonoids, stilbenes, and lignans, play an integral role in preventing the attack on plants by bacteria and fungi, as well as serving as cross-links in plant polymers. There is also mounting evidence that polyphenolic compounds play an important role in human health as well.
    [Show full text]
  • Detection of Carcinogens As Mutagens in the Salmonella/Microsome Test
    Proc. Nat. Acad. Sci. USA Vol. 73, No. 3, pp. 950-954, March 1976 Medical Sciences Detection of carcinogens as mutagens in the Salmonella/microsome test: Assay of 300 chemicals: Discussion* (prevention of cancer and genetic defects/somatic mutation/environmental insult to DNA) JOYCE MCCANN AND BRUCE N. AMES Department of Biochemistry, University of California, Berkeley, Calif. 94720 Contributed by Bruce N. Ames, January 7, 1976 ABSTRACT About 300 carcinogens and non-carcinogens Non-Carcinogens. Classification as to non-carcinogenicity of a wide variety of chemical types have been tested for mu- is usually difficult because of the varying completeness and tagenicity in the simple Salmonella/microsome test. The test uses bacteria as sensitive indicators of DNA damage, and modes of treatment in many studies and the statistical limi- mammalian liver extracts for metabolic conversion of carcin- tations inherent in animal tests (4, 8-10). Recent criteria for ogens to their active mutagenic forms. There is a high corre- adequate carcinogenicity tests are much more stringent (4, lation between carcinogenicity and mutagenicity: 90% 8-10). The test should be of adequate duration (lifetime pre- (157/175) of the carcinogens were mutagenic in the test, in- ferred in rodents) in at least two animal species, at several cluding almost all of the known human carcinogens that dose levels, and positive controls should be of the same gen- were tested. Despite the severe limitations inherent in defin- ing non-carcinogenicity, few "non-carcinogens" showed any eral chemical type as the chemical under test. The applica- degree of mutagenicity [McCann et a]. (1975) Proc.
    [Show full text]
  • Downloads/Drugs/Guidancecomplianceregulatoryinformation/Guidances/UCM347725.Pdf
    Safety Assessment of Hydrogen Peroxide as Used in Cosmetics Status: Tentative Report for Public Comment Release Date: June 28, 2018 Panel Meeting Date: September 24-25, 2018 All interested persons are provided 60 days from the above date to comment on this safety assessment and to identify additional published data that should be included or provide unpublished data which can be made public and included. Information may be submitted without identifying the source or the trade name of the cosmetic product containing the ingredient. All unpublished data submitted to CIR will be discussed in open meetings, will be available at the CIR office for review by any interested party and may be cited in a peer-reviewed scientific journal. Please submit data, comments, or requests to the CIR Executive Director, Dr. Bart Heldreth. The 2018 Cosmetic Ingredient Review Expert Panel members are: Chair, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Ronald A. Hill, Ph.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; James G. Marks, Jr., M.D.; Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Executive Director is Bart Heldreth Ph.D. This report was prepared by Lillian C. Becker, former Scientific Analyst/Writer, and Priya A. Cherian, Scientific Analyst/Writer. © Cosmetic Ingredient Review 1620 L Street, NW, Suite 1200 ♢ Washington, DC 20036-4702 ♢ ph 202.331.0651 ♢ fax 202.331.0088 [email protected] ABSTRACT: The Cosmetic Ingredient Review (CIR) Expert Panel (Panel) reviewed the safety of Hydrogen Peroxide, which is reported to function in cosmetics as an antimicrobial agent, cosmetic biocide, oral health care agent, and oxidizing agent.
    [Show full text]
  • Endocrine Disruption
    Screening for Estrogen-mimicking Chemicals: An Assessment of the E-screen and Its Implications by Edmond Toy B.A.S. Civil Engineering and Values, Technology, Science, and Society Stanford University, 1993 Submitted to the Department of Civiland Environmental Engineering in Partial Fulfillment of the Requirements for the Degrees of Master of Science in Technology and Policy and Master of Science in Civil and Environmental Engineering at the Massachusetts Institute of Technology September 1995 © 1995 Massachusetts Institute of Technology. All rights reserved. Signature of Author: Department of Civil and Enviromental Engineering August 11, 1995 r'o / I' i /E Certified by: David H. Marks, Ph.D. James Mason Crafts Professor of Civil and Environmental Engineering Director, Program in Environmental Engineering Education and Research Thesis Supervisor A/ Certified by: Richard de Neufville, Ph.D. Professor of Civil and Environmental Engineering Chairman, Technology and Policy Program Accepted by: / 1- ! J'dseph M. Sussman, Ph.D. Chairman, Departmental Committee on Graduate Studies ;;ASSACHUS'T S INSTIlU'rE OF TECHNOLOGY Barker Eng OCT 25 1995 Screening for Estrogen-mimicking Chemicals: An Assessment of the E-screen and Its Implications by Edmond Toy Submitted to the Department of Civil and Environmental Engineering on August 11, 1995 in Partial Fulfillment of the Requirements for the Degrees of Master of Science in Technology and Policy and Master of Science in Civil and Environmental Engineering There is a growing concern that chemicals in the environment may be affecting the endocrine systems of wildlife and humans. Some scientists believe that these endocrine disrupting chemicals are responsible for a wide variety of cancer and noncancer effects.
    [Show full text]
  • Oxypeucedanin: Chemotaxonomy, Isolation, and Bioactivities
    plants Review Oxypeucedanin: Chemotaxonomy, Isolation, and Bioactivities Javad Mottaghipisheh Center for Molecular Biosciences (CMBI), Institute of Pharmacy/Pharmacognosy, University of Innsbruck, Innrain 80-82, 6020 Innsbruck, Austria; [email protected] Abstract: The present review comprehensively gathered phytochemical, bioactivity, and pharma- cokinetic reports on a linear furanocoumarin, namely oxypeucedanin. Oxypeucedanin (OP), which structurally contains an epoxide ring, has been majorly isolated from ethyl acetate-soluble partitions of several genera, particularly Angelica, Ferulago, and Prangos of the Apiaceae family; and Citrus, be- longing to the Rutaceae family. The methanolic extract of Angelica dahurica roots has been analytically characterized as the richest natural OP source. This naturally occurring secondary metabolite has been described to possess potent antiproliferative, cytotoxic, anti-influenza, and antiallergic activities, as assessed in preclinical studies. In order to explore potential drug candidates, oxypeucedanin, its derivatives, and semi-synthetically optimized analogues can be considered for the complementary assessments of biological assays. Keywords: furanocoumarins; oxypeucedanin; chemotaxonomy; isolation; bioactivities; pharmacokinetics 1. Introduction Coumarins, as a broad class of secondary metabolites, are divided into diverse deriva- Citation: Mottaghipisheh, J. tives according to their structural categories, such as simple coumarins, 4-phenylcoumarins, Oxypeucedanin: Chemotaxonomy,
    [Show full text]
  • Safety Assessment of Hydrogen Peroxide As Used in Cosmetics
    Safety Assessment of Hydrogen Peroxide as Used in Cosmetics Status: Draft Report for Panel Review Release Date: May 11, 2018 Panel Meeting Date: June 4-5, 2018 The 2018 Cosmetic Ingredient Review Expert Panel members are: Chair, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Ronald A. Hill, Ph.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; James G. Marks, Jr., M.D.; Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Executive Director is Bart Heldreth Ph.D. This report was prepared by Lillian C. Becker, Scientific Analyst/Writer. © Cosmetic Ingredient Review 1620 L Street, NW, Suite 1200 ♢ Washington, DC 20036-4702 ♢ ph 202.331.0651 ♢ fax 202.331.0088 [email protected] Distributed for Comment Only -- Do Not Cite or Quote Commitment & Credibility since 1976 MEMORANDUM To: CIR Expert Panel and Liaisons From: Lillian C. Becker, M.S. Scientific Analyst and Writer Date: May 11, 2018 Subject: Safety Assessment of Hydrogen Peroxide as Used in Cosmetics Enclosed is the Draft Report of the Safety Assessment of Hydrogen Peroxide as used in Cosmetics. [hydper062018rep] In June 2016, Hydrogen Peroxide was chosen as the hair dye ingredient to be reviewed for 2017. On April 13, 2018, CIR issued the Scientific Literature Review (SLR) for this ingredient with a request for any pertinent data. The Council has submitted concentration of use data. [hydper062018data] No other data have been submitted for this ingredient. Council comments have been addressed. [hydper062018pcpc] According to FDA’s VCRP [hydper062018FDA] and the Council survey, Hydrogen Peroxide is reported to be used in hair dyes up to 15% in a professional product (that is diluted for use) and at up to 12.4% in consumer hair dyes and colors formulations; Hydrogen Peroxide is reported to be used in a total of 250 hair-coloring formulations.
    [Show full text]
  • Author Section
    AUTHOR SECTION patients who may be treated in the outpatient setting with oral M antimicrobials from patients in whom hospitalization and parenteral therapy is appropriate. Over the past decade, dramatic escalation in antimicrobial resistance among common respiratory pathogens poses Macartney K.K. et al. Nosocomial respiratory syncytial virus infections: the obstacles to antibiotic choices.We review the microbiology of com- cost-effectiveness and cost-benefit of infection control. Pediatrics. 2000; munity-acquired pneumonia, and the therapeutic strategies that are 106(3) : 520-6.p Abstract: OBJECTIVE:To determine the cost- clinically and cost effective. effectiveness and cost-benefit of an infection control program to reduce nosocomial respiratory syncytial virus (RSV) transmission in Lyon W.R. et al. A role for trigger factor and an rgg-like regulator in the tran- a large pediatric hospital. DESIGN: RSV nosocomial infection (NI) scription, secretion and processing of the cysteine proteinase of Streptococcus was studied for 8 years, before and after intervention with a target- pyogenes. EMBO J. 1998; 17(21) : 6263-75.p Abstract: The abili- ed infection control program.The cost-effectiveness of the interven- ty of numerous microorganisms to cause disease relies upon the tion was calculated, and cost-benefit was estimated by a case-control highly regulated expression of secreted proteinases. In this study, comparison. SETTING: Children’s Hospital of Philadelphia, a 304- mutagenesis with a novel derivative of Tn4001 was used to identify bed pediatric hospital. PATIENTS: All inpatients with RSV infec- genes required for the expression of the secreted cysteine proteinase tion, both community- and hospital-acquired. INTERVENTION: (SCP) of the pathogenic Gram-positive bacterium Streptococcus Consisted of early recognition of patients with respiratory symp- pyogenes.
    [Show full text]
  • TR-337: Nitrofurazone (CASRN 59-87-0) in F344/N Rats And
    NATIONAL TOXICOLOGY PROGRAM Technical Report Series No. 337 TOXICOLOGY AND CARCINOGENESIS STUDIES OF NITROFURAZONE (CAS NO. 59-87-0) IN F344/N RATS AND B6C3F1 MICE (FEED STUDIES) U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service National Institutes of Health NATIONAL TOXICOLOGY PROGRAM The National Toxicology Program (NTP), established in 1978,develops and evaluates scientific information about potentially toxic and hazardous chemicals. This knowledge can be used for protecting the health of the American people and for the primary prevention of disease. By bringing to- gether the relevant programs, staff, and resources from the U.S.Public Health Service, DHHS, the National Toxicology Program has centralized and strengthened activities relating to toxicology research, testing and test developmenthalidation efforts, and the dissemination of toxicological in- formation to the public and scientific communities and to the research and regulatory agencies. The NTP is made up of four charter DHHS agencies: the National Cancer Institute (NCI), National Institutes of Health; the National Institute of En- vironmental Health Sciences (NIEHS), National Institutes of Health; the National Center for Toxicological Research (NCTR), Food and Drug Ad- ministration; and the National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control. In July 1981,the Carcino- genesis Bioassay Testing Program, NCI, was transferred to the NIEHS. Nitrofurazone, NTP TR 337 NTP TECHNICAL REPORT ON THE TOXICOLOGY AND CARCINOGENESIS STUDIES OF NITROFURAZONE (CAS NO. 59-87-0) IN F344/N RATS AND B6C3F1 MICE (FEED STUDIES) Frank Kari, Ph.D., Chemical Manager NATIONAL TOXICOLOGY PROGRAM P.O. Box 12233 Research Triangle Park, NC 27709 June 1988 NTP TR 337 NIH Publication No.
    [Show full text]
  • Comparison of Domestic and International Law and Systems Implications for New Medical Technologies in Time of Crisis
    Denver Journal of International Law & Policy Volume 20 Number 1 Fall Article 11 May 2020 Human Rights and Access to Health Care: Comparison of Domestic and International Law and Systems Implications for New Medical Technologies in Time of Crisis Dennis McElwee Follow this and additional works at: https://digitalcommons.du.edu/djilp Recommended Citation Dennis McElwee, Human Rights and Access to Health Care: Comparison of Domestic and International Law and Systems Implications for New Medical Technologies in Time of Crisis, 20 Denv. J. Int'l L. & Pol'y 167 (1991). This Note is brought to you for free and open access by Digital Commons @ DU. It has been accepted for inclusion in Denver Journal of International Law & Policy by an authorized editor of Digital Commons @ DU. For more information, please contact [email protected],[email protected]. LEONARD v.B. SUTTON AWARD PAPER Human Rights and Access to Health Care: Comparison of Domestic and International Law and Systems Implications for New Medical Technologies in Time of Crisis I. INTRODUCTION Three years prior to the American Civil War, Abraham Lincoln stated that "a house divided against itself cannot stand.", With the ad- vent of international telecommunications, extensive travel and economic interdependence, the world is shrinking. As witnessed by the AIDS epi- demic2 and various strains of influenza,3 localized health problems in third world countries quickly find their way into one's own back yard.4 Traditional methods for differentiating domestic and international health problems have lost their meaning.5 With regard to what is currently known about past and present health crises, the "global village" has be- come a global house.
    [Show full text]
  • The Dual Antioxidant/Prooxidant Effect of Eugenol and Its Action in Cancer Development and Treatment
    nutrients Review The Dual Antioxidant/Prooxidant Effect of Eugenol and Its Action in Cancer Development and Treatment Daniel Pereira Bezerra 1 ID , Gardenia Carmen Gadelha Militão 2, Mayara Castro de Morais 3 and Damião Pergentino de Sousa 3,* ID 1 Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (IGM-FIOCRUZ/BA), Salvador 40296-710, Bahia, Brazil; [email protected] 2 Departamento de Fisiologia, Universidade Federal de Pernambuco, Recife 50670-901, Pernambuco, Brazil; [email protected] 3 Departamento de Ciências Farmacêuticas, Universidade Federal da Paraíba, João Pessoa 58051-970, Paraíba, Brazil; [email protected] * Correspondence: [email protected]; Tel.: +55-83-3209-8417 Received: 8 November 2017; Accepted: 12 December 2017; Published: 17 December 2017 Abstract: The formation of reactive oxygen species (ROS) during metabolism is a normal process usually compensated for by the antioxidant defense system of an organism. However, ROS can cause oxidative damage and have been proposed to be the main cause of age-related clinical complications and diseases such as cancer. In recent decades, the relationship between diet and cancer has been more studied, especially with foods containing antioxidant compounds. Eugenol is a natural compound widely found in many aromatic plant species, spices and foods and is used in cosmetics and pharmaceutical products. Eugenol has a dual effect on oxidative stress, which can action as an antioxidant or prooxidant agent. In addition, it has anti-carcinogenic, cytotoxic and antitumor properties. Considering the importance of eugenol in the area of food and human health, in this review, we discuss the role of eugenol on redox status and its potential use in the treatment and prevention of cancer.
    [Show full text]
  • Butyl Paraben)
    Butylparaben [CAS No. 94-26-8] Review of Toxicological Literature April 2005 Butylparaben [CAS No. 94-26-8] Review of Toxicological Literature Prepared for National Toxicology Program (NTP) National Institute of Environmental Health Sciences (NIEHS) National Institutes of Health U.S Department of Health and Human Services Contract No. N01-ES-35515 Project Officer: Scott A. Masten, Ph.D. NTP/NIEHS Research Triangle Park, North Carolina Prepared by Integrated Laboratory Systems, Inc. Research Triangle Park, North Carolina April 2005 Abstract Parabens are esters of 4-hydroxybenzoic acid that have recently been reported to have adverse effect on the male reproductive system in rodents. The toxicological database for the most commonly used parabens is quite extensive and generally indicates a low degree of systemic toxicity. In addition, several parabens have been recently reported to have estrogenic activity in experimental cell systems and animal models. Butylparaben is included among the parabens widely used as antioxidants and preservatives in foods, pharmaceuticals, and cosmetics. It is regulated by the U.S. FDA as a synthetic flavoring and adjuvant. Human exposure to butylparaben may occur via inhalation, eye or skin contact, or ingestion. Inhalation exposure causes irritation to the respiratory tract. Contact with the eyes or skin can cause irritation, redness, pain, and/or itchiness, but patch test results show that the sensitization potential of parabens is low. Ingested butylparaben is rapidly absorbed from the gastrointestinal (GI) tract, metabolized, and excreted in the urine. Large doses, however, may cause irritation to the GI tract. In mice, rats, rabbits, and dogs, butylparaben was reported to be practically nontoxic.
    [Show full text]
  • Detection of Carcinogens As Mutagens in the Salmonella/Microsome Test
    Proc. Nat. Acad. Sci. USA Vol. 73, No. 3, pp. 950-954, March 1976 Medical Sciences Detection of carcinogens as mutagens in the Salmonella/microsome test: Assay of 300 chemicals: Discussion* (prevention of cancer and genetic defects/somatic mutation/environmental insult to DNA) JOYCE MCCANN AND BRUCE N. AMES Department of Biochemistry, University of California, Berkeley, Calif. 94720 Contributed by Bruce N. Ames, January 7, 1976 ABSTRACT About 300 carcinogens and non-carcinogens Non-Carcinogens. Classification as to non-carcinogenicity of a wide variety of chemical types have been tested for mu- is usually difficult because of the varying completeness and tagenicity in the simple Salmonella/microsome test. The test uses bacteria as sensitive indicators of DNA damage, and modes of treatment in many studies and the statistical limi- mammalian liver extracts for metabolic conversion of carcin- tations inherent in animal tests (4, 8-10). Recent criteria for ogens to their active mutagenic forms. There is a high corre- adequate carcinogenicity tests are much more stringent (4, lation between carcinogenicity and mutagenicity: 90% 8-10). The test should be of adequate duration (lifetime pre- (157/175) of the carcinogens were mutagenic in the test, in- ferred in rodents) in at least two animal species, at several cluding almost all of the known human carcinogens that dose levels, and positive controls should be of the same gen- were tested. Despite the severe limitations inherent in defin- ing non-carcinogenicity, few "non-carcinogens" showed any eral chemical type as the chemical under test. The applica- degree of mutagenicity [McCann et a]. (1975) Proc.
    [Show full text]